Amy Kimball

2.2k total citations
57 papers, 1.0k citations indexed

About

Amy Kimball is a scholar working on Molecular Biology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Amy Kimball has authored 57 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Hematology and 20 papers in Pathology and Forensic Medicine. Recurrent topics in Amy Kimball's work include Multiple Myeloma Research and Treatments (19 papers), Lymphoma Diagnosis and Treatment (15 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Amy Kimball is often cited by papers focused on Multiple Myeloma Research and Treatments (19 papers), Lymphoma Diagnosis and Treatment (15 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Amy Kimball collaborates with scholars based in United States, Austria and Greece. Amy Kimball's co-authors include Thomas D. Tullius, Meletios Α. Dimopoulos, Heinz Ludwig, Rubén Niesvizky, Philippe Moreau, Robert Z. Orlowski, Albert Oriol, Hartmut Goldschmidt, Wee Joo Chng and Anita Zahlten‐Kumeli and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Amy Kimball

57 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Kimball United States	16	607	361	325	175	121	57	1.0k
Alejo A. Morales United States	13	485 0.8×	143 0.4×	188 0.6×	80 0.5×	332 2.7×	33	888
Barbara J. McClure Australia	19	371 0.6×	227 0.6×	266 0.8×	41 0.2×	488 4.0×	44	1.1k
Alexander L. Kovalchuk United States	21	616 1.0×	174 0.5×	291 0.9×	157 0.9×	398 3.3×	53	1.2k
Christi L. Wood United States	8	235 0.4×	97 0.3×	443 1.4×	77 0.4×	580 4.8×	10	1.1k
Nathan D. Montgomery United States	17	613 1.0×	50 0.1×	273 0.8×	191 1.1×	80 0.7×	53	1.1k
Samuel Y. Ng United States	12	571 0.9×	267 0.7×	206 0.6×	183 1.0×	464 3.8×	19	1.1k
Ferdinand Kappes Germany	23	1.2k 1.9×	158 0.4×	411 1.3×	55 0.3×	138 1.1×	38	1.4k
Keisuke Horikawa Australia	16	320 0.5×	68 0.2×	188 0.6×	170 1.0×	908 7.5×	28	1.3k
Friederike Herbst Germany	12	545 0.9×	65 0.2×	467 1.4×	23 0.1×	135 1.1×	34	977
Naveen Dakappagari United States	18	430 0.7×	63 0.2×	292 0.9×	48 0.3×	542 4.5×	32	919

Countries citing papers authored by Amy Kimball

Since Specialization

Citations

This map shows the geographic impact of Amy Kimball's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Kimball with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Kimball more than expected).

Fields of papers citing papers by Amy Kimball

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Kimball. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Kimball. The network helps show where Amy Kimball may publish in the future.

Co-authorship network of co-authors of Amy Kimball

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Kimball. A scholar is included among the top collaborators of Amy Kimball based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Kimball. Amy Kimball is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Major, Ajay, Justin Kline, Theodore Karrison, et al.. (2021). Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas. Haematologica. 107(7). 1608–1618. 21 indexed citations

Du, Juan, Baijun Fang, Li J, et al.. (2021). A study of carfilzomib and dexamethasone in patients with relapsed and refractory multiple myeloma in China. International Journal of Hematology. 113(3). 422–429. 5 indexed citations

Niesvizky, Rubén, Heinz Ludwig, Andrew Spencer, et al.. (2017). Overall Survival of Relapsed/Refractory Multiple Myeloma Patients Treated with Carfilzomib and Dexamethasone Vs Bortezomib and Dexamethasone: Results from the Phase 3 Endeavor Study According to Age Subgroup. Blood. 130. 1885–1885. 1 indexed citations

Weisel, Katja, David S. Siegel, Jesús F. San Miguel, et al.. (2017). Overall Survival of Patients with Relapsed Multiple Myeloma Treated with Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone According to Prior Line of Therapy and Previous Exposure to Bortezomib: Secondary Analysis of the Phase 3 Endeavor Study. Blood. 130. 1850–1850. 2 indexed citations

Dimopoulos, Meletios Α., David S. Siegel, Darrell White, et al.. (2017). Superior Efficacy of Carfilzomib and Dexamethasone (Kd56) Vs Bortezomib and Dexamethasone (Vd) in Multiple Myeloma (MM) Patients with Moderate or Serious Renal Failure: A Subgroup Analysis of the Phase 3 Endeavor Study. Blood. 130. 1845–1845. 2 indexed citations

Ludwig, Heinz, Andrew Spencer, Tibor Kovacsovics, et al.. (2017). Comparison of Proteasome Inhibition Activity between Carfilzomib and Bortezomib in the Phase 3 Endeavor Study. Blood. 130. 3125–3125. 4 indexed citations

Boccia, Ralph V., Alberto Bessudo, Richy Agajanian, et al.. (2017). A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2). Clinical Lymphoma Myeloma & Leukemia. 17(7). 433–437. 10 indexed citations

Webb, Tonya J., Gregory B. Carey, James E. East, et al.. (2016). Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses. Pathogens and Disease. 74(6). ftw055–ftw055. 26 indexed citations

Kvarta, Mark D., Deva Sharma, Rudolph J. Castellani, et al.. (2016). Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination. BMC Neurology. 16(1). 72–72. 32 indexed citations

10.

Smith, David F., et al.. (2016). Improvement in hearing loss over time in Cornelia de Lange syndrome. International Journal of Pediatric Otorhinolaryngology. 87. 203–207. 4 indexed citations

11.

Gade, Padmaja, Amy Kimball, Douglas D. Ross, et al.. (2016). Death-associated Protein Kinase-1 Expression and Autophagy in Chronic Lymphocytic Leukemia Are Dependent on Activating Transcription Factor-6 and CCAAT/Enhancer-binding Protein-β. Journal of Biological Chemistry. 291(42). 22030–22042. 14 indexed citations

12.

Simpson, Haley, Rashid Khan, Chang Song, et al.. (2015). Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma. PLoS ONE. 10(11). e0141906–e0141906. 19 indexed citations

13.

Jasielec, Jagoda, Amy Kimball, Kenneth S. Cohen, et al.. (2014). Temsirolimus (TEM) and lenalidomide (LEN) in relapsed/refractory Hodgkin lymphoma including in patients with prior exposure to brentuximab vedotin (BV).. Journal of Clinical Oncology. 32(15_suppl). 8567–8567. 2 indexed citations

14.

Yared, Jean A., Amy Kimball, Maria R. Baer, Huzefa Bahrain, & Michael Auerbach. (2013). Rituximab Maintenance Therapy Until Progression After Rituximab and Chemotherapy Induction in Patients With Follicular Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 13(3). 253–257. 7 indexed citations

15.

Ning, Yi, et al.. (2013). Characterization of a case of follicular lymphoma transformed into B-lymphoblastic leukemia. Molecular Cytogenetics. 6(1). 34–34. 10 indexed citations

16.

Benke, James R., Antonie D. Kline, Howard P. Levy, et al.. (2012). Insomnia in Cornelia de Lange Syndrome. International Journal of Pediatric Otorhinolaryngology. 76(7). 972–975. 10 indexed citations

17.

Kline, Antonie D., et al.. (2010). Characterization of sleep disturbance in Cornelia de Lange Syndrome. International Journal of Pediatric Otorhinolaryngology. 75(2). 215–218. 17 indexed citations

18.

Kline, Antonie D., Marco A. Grados, Paul D. Sponseller, et al.. (2007). Natural history of aging in Cornelia de Lange syndrome. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 145C(3). 248–260. 118 indexed citations

19.

Kimball, Amy, et al.. (1995). Chemical probe and missing nucleoside analysis of Flp recombinase bound to the recombination target sequence. Nucleic Acids Research. 23(15). 3009–3017. 12 indexed citations

20.

Kimball, Amy, Gregory Milman, & Thomas D. Tullius. (1989). High-Resolution Footprints of the DNA-Binding Domain of Epstein- Barr Virus Nuclear Antigen 1. Molecular and Cellular Biology. 9(6). 2738–2742. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact